Healthcare, Pharma See Record Q3 Deals

New Delhi: The healthcare and pharma sector saw an overall 64 deals, valued at $2.8 billion in Q3 of 2024, marking the sector’s highest quarterly volumes in three years, according to a report on Tuesday.

The report by Grant Thornton Bharat showed that mergers and acquisitions, and private equity deal volumes increased significantly, with 59 deals worth $2.2 billion, the highest since Q4 2021.

However, Q3 2024 saw a 47 per cent decline in deal values compared to Q2 2024.

The decline was mainly due to fewer high-value deals, with only two deals worth $1.8 billion. In contrast, Q2/2024 had 11 high-value deals (over $100 million) totaling $3.4 billion.